Will you be at the World Orphan Drug Congress? Let’s meet!
You need delivery on-time: The combined leadership expertise, unique geographic placement and highly experienced operational team at Worldwide Clinical Trials means that we can deliver your studies on-time, every time!
You want a team attuned to your unique challenges: Worldwide provides unrivaled therapeutic expertise and operational excellence across all phases of development in neuroscience, cardiovascular disease, inflammatory disorders, and rare disease.
You’re in luck! Our team will be available during the World Orphan Drug Congress to discuss a plan that can help maximize the success of your projects.
Visit us at Booth #311 or schedule a meeting today!
Executive Director, Global Project Management, Rare Disease Franchise Lead
Express your interest by completing the form on the right.
- Emerging opportunities for an “outside the box” approach to study and program design
- The importance of appreciating the illness, not just understanding the disease
- Family engagement informing both trial design as well as operational strategy
- Translating innovative designs into predictable high quality execution
About Worldwide Clinical Trials
Worldwide Clinical Trials employs more than 1,400 professionals around the world, with offices in North and South America, Eastern and Western Europe, Russia and Asia. One of the world’s leading, full-service contract research organizations (CROs), we partner with sponsors in the pharmaceutical and biotechnology industries to deliver fully integrated clinical development and bioanalytical services, extending from first-in-human through phase IV studies. Grounded in medicine and science, we help sponsors move from medical discovery into clinical development and commercialization, helping bring innovative solutions to market that deliver enhanced value and improve patient lives. Our employees are among the best in their fields – clinicians, scientists, operational and regulatory specialists who offer expertise across a range of therapeutic areas, including neuroscience, cardiovascular diseases, immune-mediated inflammatory disorders (IMID), and rare diseases. For more information, visit our website.